COVID’s Outsized Heart Risk; Prehab for Cardiac Surgery; Telerobotic Valve Repair

Severe COVID-19 infection was associated with major cardiac events as much as — and in some cases more than — having a history of heart disease, U.K. Biobank data showed. (Arteriosclerosis, Thrombosis, and Vascular Biology)

An artificial intelligence (AI) model performed well in predicting long-term mortality in people with congenital heart disease. (European Heart Journal)

Several Medicare administrative contractors have agreed to cover AI-enabled quantitative coronary plaque analysis such as Cleerly’s quantitative coronary topography scans and Elucid’s PlaqueIQ software.

Multimodal personalized teleprehabilitation before cardiac surgery successfully reduced major adverse cardiovascular events 1 year after surgery. (Journal of the American College of Cardiology)

Higher BMI tracked with a higher risk of aortic stenosis in women. (Journal of the American Heart Association)

Native Hawaiian and Pacific Islander adults ranked third for highest cardiovascular death rates in the U.S., behind Black and white adults. (Annals of Internal Medicine)

A Chinese group reported the first-in-human experience of telerobotic transcatheter edge-to-edge repair, with the patient — who had grade 4+ functional mitral regurgitation — located thousands of miles away from the operator. (JACC: Cardiovascular Interventions)

In the phase III STEM-AMI OUTCOME trial, administering granulocyte colony-stimulating factor did not necessarily improve outcomes for people with left ventricular dysfunction after successful percutaneous coronary intervention for a large ST-elevation myocardial infarction. (Heart)

Abbott announced FDA clearance of the Advisor HD Grid X Mapping Catheter, Sensor Enabled, for use during pulsed field ablation and radiofrequency ablation procedures.

Implantable cardioverter-defibrillators were no better than amiodarone for survival in chronic Chagas cardiomyopathy, though they did reduce the risk of sudden cardiac death and heart failure in the CHAGASICS trial. (JAMA Cardiology)

A federal judge rejected Novartis’ motion to declare as unlawful the FDA approval of a generic sacubitril/valsartan (Entresto) from MSN Laboratories.

For a minor nondisabling acute ischemic stroke, dual antiplatelet therapy was tied to better prevention of early neurological deterioration with a better safety profile compared with IV alteplase. (Stroke)

Contego Medical announced FDA approval of the Neuroguard IEP System that combines a high-performance stent, an integrated dilation balloon, and integrated filter for embolic protection.

For selected children with large-vessel or medium-vessel occlusion strokes, endovascular thrombectomy compared favorably to medical treatment alone for improving functional outcomes, based on registry data. (Lancet Child & Adolescent Health)

Mendelian randomization analysis finds no causal relationship between non-alcohol fatty liver disease and coronary artery calcification. (European Journal of Preventive Cardiology)

Please enable JavaScript to view the

comments powered by Disqus.